Skip to Content
Merck
CN

Changes in debrisoquine hydroxylation capacity following liver surgery.

Human & experimental toxicology (1994-08-01)
S C Mitchell, R R Shah, D G Clements, R L Smith
ABSTRACT

Liver transplantation or the surgical construction of portacaval shunts may radically alter an individual's debrisoquine hydroxylation capacity. Good clinical management should encompass a full awareness of such changing needs and problems in patients who undergo hepatic surgery.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-4-Hydroxydebrisoquin sulfate